187 related articles for article (PubMed ID: 26910220)
1. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Yu S; Kwon MJ; Lee EH; Park H; Woo HY
J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Roche Cobas(®) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia.
Phillips S; Garland SM; Tan JH; Quinn MA; Tabrizi SN
J Clin Virol; 2015 Jan; 62():63-5. PubMed ID: 25542473
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
6. SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.
Naeem RC; Goldstein DY; Einstein MH; Ramos Rivera G; Schlesinger K; Khader SN; Suhrland M; Fox AS
Lab Med; 2017 Aug; 48(3):207-213. PubMed ID: 28379422
[TBL] [Abstract][Full Text] [Related]
7. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
8. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
9. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Park Y; Lee E; Choi J; Jeong S; Kim HS
J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
[TBL] [Abstract][Full Text] [Related]
11. Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens.
Siddiqi A; Spataro M; McIntire H; Akhtar I; Baliga M; Flowers R; Lin E; Guo M
Cancer; 2009 Oct; 117(5):318-25. PubMed ID: 19693966
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.
Lee DH; Hwang NR; Lim MC; Yoo CW; Joo J; Kim JY; Park SY; Hwang SH
Ann Clin Biochem; 2016 Sep; 53(Pt 5):561-7. PubMed ID: 26486441
[TBL] [Abstract][Full Text] [Related]
13. EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1033-6. PubMed ID: 27048314
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media.
Jang D; Ratnam S; Smieja M; Speicher DJ; Arias M; Clavio A; Costescu D; Elit L; Huang S; Herrero-Garcia E; Joseph AM; Jiang H; Needle R; Chernesky M
Tumour Virus Res; 2021 Dec; 12():200224. PubMed ID: 34242835
[TBL] [Abstract][Full Text] [Related]
15. Specimen Age Stability for Human Papilloma Virus DNA Testing Using BD SurePath.
Kubik MJ; Permenter T; Saremian J
Lab Med; 2015; 46(1):51-4; quiz e13. PubMed ID: 25617393
[TBL] [Abstract][Full Text] [Related]
16. Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection.
Ko K; Kwon MJ; Lee EH; Woo HY; Park H
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27387091
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the compatibility of the Digene media when performing the Roche linear array human papillomavirus genotyping test.
Hong JH; Lee JK; Song ES; Lee JM; Kim MK
Arch Gynecol Obstet; 2009 Oct; 280(4):613-8. PubMed ID: 19229548
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
[TBL] [Abstract][Full Text] [Related]
20. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
